Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer’s Disease
Go back to Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer’s Disease| Arbios Systems, Inc. (NASDAQ: ABOS) | Delayed: 3.18 +0.09 (2.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.09 | 52 Week High | $0.23 | |||
| Open | $3.07 | 52 Week Low | $0.00 | |||
| Day High | $3.23 | P/E | N/A | |||
| Day Low | $3.03 | EPS | $0.00 | |||
| Volume | 315,433 | |||||
